{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-017225","form_type":"8-K","ticker":"PIII","cik":"0001832511","company_name":"P3 Health Partners Inc.","filed_at":"2023-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.997458+00:00","generated_at":"2026-06-15T06:59:46.818656+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"P3 Q1 capitated revenue up 11%; net loss improves 14%; medical margin surges 58%","bullets":["Capitated revenue $298.7M (+11% YoY); net loss $52.4M, improved from $60.8M in Q1 2022.","Medical margin $39.2M (13.1% of capitated revenue), up 58% YoY; network contribution $16.5M (+114%).","Adjusted EBITDA loss $19.1M; full-year guidance raised to loss $35-55M from prior expectations.","FY 2023 guidance: revenue $1.2-1.25B, medical margin $155-175M, members 115k-120k."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-017225","json":"https://secwatch.observer/filing/0001628280-23-017225.json","markdown":"https://secwatch.observer/filing/0001628280-23-017225.md","text":"https://secwatch.observer/filing/0001628280-23-017225.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832511/000162828023017225/0001628280-23-017225-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832511/000162828023017225/piii-20230510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T06:59:46.818656+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dd3b9a3d5a6d79b87743bd89e6d6b6eb347ae702","claim":"P3 Health Partners Inc. reported the first quarter ended March 31, 2023 results: revenue $298.7 million, net income $52.4 million.","evidence_excerpt":"a model where we believe the patient, providers, payors and ultimately our shareholders win,” Dr. Abdou concluded. First Quarter 2023 Financial Results • Capitated revenue was $298.7 million, an increase of 11% compared to $269.7 million in the first quarter of the prior year, and an increase of 18% compared to the fourth quarter of 2022 • Net loss was $52.4 million,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000162828023017225/0001628280-23-017225-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Revenue","value":"$298.7 million"},{"label":"Net income","value":"$52.4 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e81373ea5b1e2b474f9af7cf1fad05c15429ba2e","claim":"P3 Health Partners Inc. reported year ending December 31, 2023 results: revenue $ 1,200 $ 1,250. Guidance raised.","evidence_excerpt":"of 250% compared to fourth quarter of 2022 Full-Year 2023 Guidance Year Ended December 31, 2023 Low High Medicare Advantage Members 115,000 120,000 Total Revenues (in millions) $ 1,200 $ 1,250 Medical margin (2) (in millions) $ 155 $ 175 Medical margin (2) PMPM $ 120 $ 130 Adjusted EBITDA (2) Loss (in millions) $ (55) $ (35) (1) Adjusted EBITDA, Adjusted EBITDA","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000162828023017225/0001628280-23-017225-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ending December 31, 2023"},{"label":"Revenue","value":"$ 1,200 $ 1,250"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}